ZimVie announces FDA approval for Mobi-C implant

ZimVie announced that on August 1st, 2023, the U.S. Food and Drug Administration approved a smaller height of the Mobi-C Cervical Disc in seven footprints that will address the anatomical needs of the U.S. patient population. Physicians have used the market-leading Mobi-C device for cervical disc replacement at one level or two contiguous levels to treat patients in France since 2004 and in the U.S. since 2013 when it became the first cervical disc approved for one and two levels by the FDA.